Suppr超能文献

新发和继发进展型多发性硬化症中P2X受体结合——一项[C]SMW139正电子发射断层扫描研究

P2X -receptor binding in new-onset and secondary progressive MS - a [C]SMW139 PET study.

作者信息

Lehto Jussi, Aarnio Richard, Tuisku Jouni, Sucksdorff Marcus, Koivumäki Esa Mikko, Nylund Marjo, Helin Semi, Rajander Johan, Danon Jonathan, Gilchrist Jayson, Kassiou Michael, Oikonen Vesa, Airas Laura

机构信息

Turku PET Centre, Turku, Finland.

Neurocenter, Turku University Hospital, Turku, Finland.

出版信息

EJNMMI Res. 2024 Dec 5;14(1):123. doi: 10.1186/s13550-024-01186-3.

Abstract

BACKGROUND

PET imaging of activated microglia has improved our understanding of the pathology behind disability progression in MS, and pro-inflammatory microglia at 'smoldering' lesion rims have been implicated as drivers of disability progression. The P2X R is upregulated in the cellular membranes of activated microglia. A single-tissue dual-input model was applied to quantify P2X R binding in the normal appearing white matter, perilesional areas and thalamus among progressive MS patients, healthy controls and newly diagnosed relapsing MS patients.

RESULTS

Overall, tracer uptake in the MS brain was not significantly higher compared to HCs. In the 3 mm perilesional rim of all T1 lesions, tracer binding was higher among relapsing patients compared to progressive patients. Tracer binding was higher in males compared to females. Disease duration correlated with tracer binding in the normal appearing white matter. Age correlated negatively with tracer binding in the perilesional rims.

CONCLUSIONS

Even as binding estimates obtained with the dual-input model were consistent with the expected distribution of P2X Rs in the MS brain, the small free fraction of the parent tracer may limit its accuracy and applicability, and binding estimates between subjects were highly variable. Conclusive evidence for the applicability of [C]SMW139 to detect MS-related diffuse smoldering inflammation was not obtained.

摘要

背景

对活化小胶质细胞的正电子发射断层扫描(PET)成像增进了我们对多发性硬化症(MS)中残疾进展背后病理机制的理解,并且“隐匿性”病灶边缘的促炎性小胶质细胞被认为是残疾进展的驱动因素。P2X受体在活化小胶质细胞的细胞膜中上调。应用单组织双输入模型来量化进展型MS患者、健康对照者和新诊断的复发型MS患者正常外观白质、病灶周围区域和丘脑中P2X受体的结合情况。

结果

总体而言,与健康对照者相比,MS患者大脑中的示踪剂摄取没有显著更高。在所有T1病灶的3毫米病灶周围边缘,复发型患者的示踪剂结合高于进展型患者。男性的示踪剂结合高于女性。疾病持续时间与正常外观白质中的示踪剂结合相关。年龄与病灶周围边缘的示踪剂结合呈负相关。

结论

尽管双输入模型获得的结合估计值与MS大脑中P2X受体的预期分布一致,但母体示踪剂的小游离部分可能会限制其准确性和适用性,并且受试者之间的结合估计值高度可变。未获得[C]SMW139用于检测MS相关弥漫性隐匿性炎症适用性的确凿证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f04/11621262/2100a510c12d/13550_2024_1186_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验